Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Quest Diagnostics (DGX)
NYSE:DGX
Quest Diagnostics (DGX) Stock Price & Analysis
828 Followers
DGX Stock Chart & Stats
Day’s Range$134.05 - $135.99
52-Week Range― - ―
Previous Close$135.42
Volume601.74K
Average Volume (3M)N/A
Market Cap
$15.13B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Jul 24, 2024EPS Estimate
$2.35Last Dividend Ex-Date
Apr 05, 2024Dividend Yield2.1%
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$145.45Price Target Upside8.33% Upside
Rating ConsensusHold
Number of Analyst Covering12
Quest Diagnostics News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAnalyst recommendation for DGX stock is a Buy, with a raised price target to $155, based on strong Q1 performance and positive business trends.
Growth ProspectsDGX's pipeline for additional outreach lab M&A remains promising, with potential for further growth not yet included in guidance.
Operational EfficiencyProductivity and customer service initiatives, such as the Invigorate cost savings program, are on track and driving efficiency improvements.
Bears Say
Earnings GuidanceInitial 2024 guidance, which came in below expectations mainly due to higher interest costs.
Financial PerformanceMargins were down year-over-year in the face of COVID pricing normalization, Haystack dilution, and wage inflation.
Regulatory RiskPotential FDA regulation of LDTs continues to weigh on stocks, with Final Rule possible later this month.
---
Ownership Overview
1.77% Insiders
30.95% Mutual Funds
29.15% Other Institutional Investors
38.13% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DGX FAQ
What was Quest Diagnostics’s price range in the past 12 months?
Currently, no data Available
What is Quest Diagnostics’s market cap?
Currently, no data Available
When is Quest Diagnostics’s upcoming earnings report date?
Quest Diagnostics’s upcoming earnings report date is Jul 24, 2024 which is in 87 days.
How were Quest Diagnostics’s earnings last quarter?
Quest Diagnostics released its earnings results on Apr 23, 2024. The company reported $2.04 earnings per share for the quarter, beating the consensus estimate of $1.856 by $0.184.
Is Quest Diagnostics overvalued?
According to Wall Street analysts Quest Diagnostics’s price is currently Undervalued.
Does Quest Diagnostics pay dividends?
Quest Diagnostics pays a Quarterly dividend of $0.75 which represents an annual dividend yield of 2.1%. See more information on Quest Diagnostics dividends here
What is Quest Diagnostics’s EPS estimate?
Quest Diagnostics’s EPS estimate is $2.35.
How many shares outstanding does Quest Diagnostics have?
Currently, no data Available
What happened to Quest Diagnostics’s price movement after its last earnings report?
Quest Diagnostics reported an EPS of $2.04 in its last earnings report, beating expectations of $1.856. Following the earnings report the stock price went up 5.081%.
Which hedge fund is a major shareholder of Quest Diagnostics?
Among the largest hedge funds holding Quest Diagnostics’s share is Davis Selected Advisers. It holds Quest Diagnostics’s shares valued at 368M.
---
Quest Diagnostics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$145.45 (8.33% Upside)
$145.45 (8.33% Upside)
Blogger Sentiment
Bullish
DGX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 978.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $316.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.3%
Last 30 Days >0.1%
Last 30 Days >0.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-6.54%
12-Months-Change
Fundamentals
Return on Equity
13.49%
Trailing 12-Months
Asset Growth
9.07%
Trailing 12-Months
Company Description
Quest Diagnostics
Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
---
DGX Earnings Call
Q1 2024
0:00 / 0:00
---
DGX Revenue Breakdown
97.02% Diagnostic Information Services
2.98% All other operating segments
---
DGX Stock 12 Months Forecast
Average Price Target
$145.45
▲(8.33% Upside)
Technical Analysis
Best Analysts Covering DGX
1 Year
1 Year Success Rate
23/36 ratings generated profit
1 Year Average Return
+6.01%
reiterated a buy rating 5 days ago
Copying Ann Hynes's trades and holding each position for 1 Year would result in 63.89% of your transactions generating a profit, with an average return of +6.01% per trade.
---